cozaar comp 100 mg/12.5 mg film-coated tablets
pco manufacturing ltd. - hydrochlorothiazide; losartan potassium - film-coated tablet - 100 mg/12.5 milligram(s) - losartan and diuretics
cosartal plus 100 mg/12.5 mg film-coated tablets
actavis group ptc ehf - hydrochlorothiazide; losartan potassium - film-coated tablet - 100/12.5 milligram(s) - angiotensin ii antagonists and diuretics; losartan and diuretics
cozaar comp 50 mg/12.5 mg film-coated tablets
pco manufacturing ltd. - hydrochlorothiazide; losartan potassium - film-coated tablet - 50 mg/12.5 milligram(s) - angiotensin ii antagonists and diuretics; losartan and diuretics
losartan potassium msd 12.5 milligram film coated tablet
merck sharp & dohme ireland (human health) limited - losartan potassium - film coated tablet - 12.5 milligram - angiotensin ii antagonists, plain
losartan potassium msd 50 milligram film coated tablet
merck sharp & dohme ireland (human health) limited - losartan potassium - film coated tablet - 50 milligram - angiotensin ii antagonists, plain
bosentan rbx bosentan (as monohydrate) 62.5 mg film-coated tablet bottle
sun pharma anz pty ltd - bosentan monohydrate, quantity: 64.541 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; sodium starch glycollate type a; glycerol dibehenate; magnesium stearate; povidone; maize starch; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; ethylcellulose - bosentan is indicated for the treatment of,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with scleroderma or,? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms
bosentan rbx bosentan (as monohydrate) 62.5 mg film-coated tablet blister pack
sun pharma anz pty ltd - bosentan monohydrate, quantity: 64.541 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; glycerol dibehenate; maize starch; sodium starch glycollate type a; magnesium stearate; povidone; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; ethylcellulose - bosentan is indicated for the treatment of,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with scleroderma or,? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms
bosentan rbx bosentan (as monohydrate) 125 mg film-coated tablet bottle
sun pharma anz pty ltd - bosentan monohydrate, quantity: 129.083 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; glycerol dibehenate; povidone; maize starch; magnesium stearate; pregelatinised maize starch; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; ethylcellulose - bosentan is indicated for the treatment of,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with scleroderma or,? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms
bosentan apo bosentan (as monohydrate) 62.5 mg film-coated tablet bottle
arrotex pharmaceuticals pty ltd - bosentan monohydrate, quantity: 64.541 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; glycerol dibehenate; povidone; maize starch; pregelatinised maize starch; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; ethylcellulose - bosentan is indicated for the treatment of,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with scleroderma or,? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms
bosentan rbx bosentan (as monohydrate) 125 mg film-coated tablet blister pack
sun pharma anz pty ltd - bosentan monohydrate, quantity: 129.083 mg - tablet, film coated - excipient ingredients: glycerol dibehenate; povidone; pregelatinised maize starch; magnesium stearate; sodium starch glycollate type a; maize starch; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; ethylcellulose - bosentan is indicated for the treatment of,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with scleroderma or,? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms